Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Clinical Pharmacokinetics|May 6, 2005
Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavirOlga Millán, Mercè Brunet, Jaume Martorell, et al.
Journal of Inherited Metabolic Disease|April 16, 2021
Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiranJordi To-Figueras, Robin Wijngaard, Judit García-Villoria, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Genetic Variants Associated with Fluoropyrimidine-Induced Toxicity in Real-World Patients After Pre-Emptive DPYD Pharmacogenetic TestingMaría Rodríguez-García, Sara Salvador-Martín, Mariam Stephanie Rojas Piedra, et al.
Translational Psychiatry|July 27, 2019
A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatmentsMaria J Arranz, Alex Gonzalez-Rodriguez, Josefina Perez-Blanco, et al.
Pharmacopsychiatry|June 17, 2025
Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic TreatmentsMarc Cendrós, Rosa Catalán, Mercè Torra, et al.
Kidney International|January 10, 2014
Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipientsHelena Colom, Núria Lloberas, Franc Andreu, et al.
Therapeutic Drug Monitoring|July 16, 2013
Pharmacokinetic study of dual therapy with raltegravir 400 mg twice daily and Darunavir/Ritonavir 800/100 mg once daily in HIV-1-infected patientsMaria Martínez-Rebollar, Ana Muñoz, Iñaki Pérez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 1, 2008
Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune responseMontserrat Rigol, Núria Solanes, Alessandro Sionis, et al.
Therapeutic Drug Monitoring|March 17, 2016
Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific CommitteeChristoph Seger, Maria Shipkova, Uwe Christians, et al.
Pharmacogenetics and Genomics|December 20, 2017
Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patientsMiguel A Gómez-Bravo, María Apellaniz-Ruiz, Magdalena Salcedo, et al.
Pageof 8